Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | B. Ljepoja et al., PLoS ONE, 2019, 14(11): e0224314, doi.org/10.1371/journal.pone.0224314 | Link | |
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | H. Liu et al., J. Lipid Res., Mar 2013; 54: 776 - 785 | Link | |
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | K. J. Lee et al., Exp. Cell Research, 2015, 336: 211-222; doi.org/10.1016/j.yexcr.2015.07.010 | ||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | Metafectene | publication | Y. V. Kuznetsov et al., Europ. J. of Med. Chem., 2018, 143: 670-682, doi.org/10.1016/j.ejmech.2017.11.042 | |||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | X. Wu et al., PNAS, Nov 2016, 113: E6965 - E6973 | ||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | K2 Transfection System | publication | A. Hermawan et al., Dissertation, 2015, Ludwig-Maximilians-Universität München | Link | ||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | miRNA | K2 Transfection System | publication | B. Ljepoja, Dissertation, 2019, Ludwig-Maximilians-Universität München | Link | ||
MC7-L1 |
Mouse mammary carcinoma cell line | Mouse | breast | cell line | adherent | plasmid | K2 Transfection System | publication | W. Wang et al., Mol. and Cellular Endocrinology, 2018, 477: 57–69, doi.org/10.1016/j.mce.2018.06.001 | Link | |||
MC7-L1 |
Mouse mammary carcinoma cell line | Mouse | breast | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
||||
MC4-L3 |
Mouse mammary carcinoma cell line | Mouse | breast | cell line | adherent | plasmid | K2 Transfection System | publication | W. Wang et al., Mol. and Cellular Endocrinology, 2018, 477: 57–69, doi.org/10.1016/j.mce.2018.06.001 | Link | |||
MC4-L2 |
Mouse mammary carcinoma cell line | Mouse | breast | cell line | adherent | plasmid | K2 Transfection System | publication | W. Wang et al., Mol. and Cellular Endocrinology, 2018, 477: 57–69, doi.org/10.1016/j.mce.2018.06.001 | Link | |||
MC3T3-E1 |
Mouse osteoblast cell line | ATCC CRL-2593 | Mouse | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | C.-L. Tsai et al., Journal of Biomedical Science, 2014, 21:12, doi:10.1186/1423-0127-21-12 | Link | |
MC3T3-E1 |
Mouse osteoblast cell line | ATCC CRL-2593 | Mouse | bone | cell line | adherent | plasmid | Metafectene | publication | H.-J. Kim et al., Scientific Reports, Feb. 2017, 7: 42882, DOI: 10.1038/srep42882 | Link | ||
MC3T3-E1 |
Mouse osteoblast cell line | ATCC CRL-2593 | Mouse | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | C.-L. Tsai et al., Bone, 2014, 60 :186-197, doi.org/10.1016/j.bone.2013.12.014 | ||
MC3T3-E1 |
Mouse osteoblast cell line | ATCC CRL-2593 | Mouse | bone | cell line | adherent | plasmid | Metafectene | publication | C.-L. Tsai et al., Journal of Biomedical Science, 2014, 21:12, doi:10.1186/1423-0127-21-12 | Link | ||
MC3T3-E1 |
Mouse osteoblast cell line | ATCC CRL-2593 | Mouse | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | Y.-y. Li et al., FASEB, 2012 | ||
mBMDM |
Mouse bone marrow derived macrophages | Mouse | immune system | primary cell | plasmid | K2 Transfection System | publication | C. A. Nold-Petry et al., Nature Immunology, 2015, 16 (4): 354, doi:10.1038/ni.310 | |||||
Ma-Mel-86a |
Malignant melanoma cell line | Human | skin | cell line | plasmid | stable transfection | Metafectene | publication | N. Ullrich et al., Cancer Res., May 2015; 75: 1897 - 1907 | Link | |||
Ma-Mel-86a |
Malignant melanoma cell line | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene | publication | S. Löffek et al., Front. Oncol., 2015, 5:234; doi: 10.3389/fonc.2015.00234 | Link | ||
Ma-Mel-2 |
Malignant melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | A. Vamanet al., 2015, PLoS ONE 10(6): e0129219; doi:10.1371/journal.pone.0129219 | Link | ||
M3K |
Drug-resistant breast cancer cell line (derivative of MCF7) | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | L. J. Barlow, Dissertation, 2020, University Graduate School | Link | ||
M21 |
Human melanoma cell line | Human | skin | cell line | adherent | oligonucleotide | DOTAP | publication | M. M. M. Enriquez ez al., PLoSONE13(11):e0206818, doi.org/10.1371/journal.pone.0206818 | Link | |||
M2-10B4 |
Murine bone marrow stroma cells | ATCC CRL-1972 | Murine | bone | unknown | adherent | plasmid | Metafectene PRO | application note | ![]() |
|||
M14 |
Human metastatic melanoma cells | Human | skin | cell line | adherent | plasmid | CRISPR | Metafectene SI | publication | A. Sarma et al., The American J. of Pathology, 2021, 191, 2, doi.org/10.1016/j.ajpath.2020.10.015 | Link | ||
M14 |
Human metastatic melanoma cells | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene SI | publication | A. Sarma et al., The American J. of Pathology, 2021, 191, 2, doi.org/10.1016/j.ajpath.2020.10.015 | Link |